Advanced Nasopharyngeal Carcinoma with Generalized Lymphadenopathy Masquerade as Lymphoma

Document Type : Case Report

Authors

1 Department of Otorhinolaryngology-Head & Neck Surgery, School of Medical Sciences, University Sains Malaysia Health Campus, 16150 Kota Bharu, Kelantan, Malaysia.

2 Department of Radiology, School of Medical Sciences, University Sains Malaysia, Health Campus, 16150 Kota Bharu, Kelantan, Malaysia.

3 Department of Pathology, School of Medical Sciences, University Sains Malaysia, Health Campus, 16150 Kota Bharu, Kelantan, Malaysia.

4 Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150 Kota Bharu, Kelantan, Malaysia.

5 Department of Internal Medicine, School of Medical Sciences, University Sains Malaysia, Health Campus, 16150 Kota Bharu, Kelantan, Malaysia.

10.22038/ijorl.2022.62088.3133

Abstract

Introduction:
Nasopharyngeal carcinoma (NPC) is a nasopharyngeal epithelial neoplasm that has distinct aetiological, epidemiological and biological characteristics compared to other head and neck malignancies. Patients usually present late due to non-specific symptoms and deep location of the tumour in the nasopharynx.
Case Report
We would like to highlight a case of advanced NPC presenting with generalised lymphadenopathy, without the presence of an obvious nasopharyngeal mass that masqueraded as lymphoma in the initial stage.
Conclusions:
NPC may share clinical features with other sinonasal pathologies or other malignant lymphoproliferative disorders that lead to a delay in diagnosis. NPC should be one of the differential diagnoses for any cases presenting with cervical lymphadenopathy, especially in adult male patients originating from East or Southeast Asia. Early diagnosis and treatment are crucial because early-stage NPC has an excellent chemoradiotherapy response and high survival rate.

Keywords


  1. Tsang RKY, Kwong DLW. Nasopharyngeal carcinoma. In: Watkinson JC, Clarke RW editors. Scott-Brown’s Otorhinolaryngology Head & Neck Surgery. 8th ed. USA: Taylor & Francis Group; 2019. p. 93-110.
  2. Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019; 394(10192): 64-80. doi:10.1016/S0140-6736(19) 30956-0.
  3. Chang ET, Ye W, Zeng YX, Adami HO. The evolving epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2021;30(6):1035-1047. doi: 10.1158/1055-9965. EPI-20-1702.
  4. Suzina SA, Hamzah M. Clinical presentation of patients with nasopharyngeal carcinoma. Med J Malaysia. 2003;58(4):539-545.
  5. Tiong TS, Selva KS. Clinical presentation of nasopharyngeal carcinoma in Sarawak Malaysia. Med J Malaysia. 2005;60(5):624-628.
  6. Ho FC, Tham IW, Earnest A, Lee KM, Lu JJ. Patterns of regional lymph node metastasis of

 

nasopharyngeal carcinoma: a meta-analysis of clinical evidence. BMC Cancer. 2012; 12:98. doi:10.1186/1471-2407-  12-98.

  1. DeLair DF, Corben AD, Catalano JP, Vallejo CE, Brogi E, Tan LK. Non-mammary metastases to the breast and axilla: A study of 85 cases. Mod Pathol. 2013; 26(3):343-349. doi:10.1038/ modpathol. 2012.191.
  2. Mohammad Nasir Z, Subha ST. A rare presentation recurrent nasopharyngeal carcinoma with axillary lymph node metastasis. Egypt J Ear Nose Throat Allied Sci. 2019;20(3):156-8. doi: 10.21608/ejentas.2019.12632.1109.
  3. Adham M, Kurniawan AN, Muhtadi AI, Roezin A, Hermani B, Gondhowiardjo S, et al. Nasopharyngeal carcinoma in Indonesia: Epidemiology, incidence, signs, and symptoms at presentation. Chin J Cancer. 2012;31(4):185-196. doi:10.5732/cjc.011.10328.
  4. Abdullah B, Rasid NSA, Lazim NM, Volgger V, Betz CS, Mohammad ZW, et al. Ni endoscopic classification for Storz Professional Image Enhancement System (SPIES) endoscopy in the detection of upper aerodigestive tract (UADT) tumours. Sci Rep. 2020;10(1):6941. doi:10.1038/s41598-020-64011-6.
  5. Ke K, Wang H, Fu S, Zhang Z, Duan L, Liu D, et al. Epstein-Barr virus-encoded RNAs as a survival predictor in nasopharyngeal carcinoma. Chin Med J (Engl). 2014;127(2):294-299. doi: 10.3760/cma. j. issn. 0366-6999.20132206.
  6. Farias TP, Dias FL, Lima RA, Kligerman J, de Sá GM, Barbosa MM, et al. Prognostic factors and outcome for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129(7):794-799. doi:10.1001/archotol.129.7.794.
  7. Lee AW, Lin JC, Ng WT. Current management of nasopharyngeal cancer. Semin Radiat Oncol. 2012; 22(3):233-244. doi: 10.1016/j.semradonc. 2012. 03.008.